Barriers to pain management in the rehabilitation of the surgical oncology patient

Journal of Surgical Oncology

Volumn 95, Issue 5, 2007, Pages 427-435

  Silver, Julie ^a,b,c,f   Mayer, R Samuel ^d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Physical Medicine and Rehabilitation   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f NONE   (United States)

Author keywords

Cancer pain; Opioid; Rehabilitation; Surgical oncology

Indexed keywords

ALTRETAMINE; AMIFOSTINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYTARABINE; DOCETAXEL; IFOSFAMIDE; LEVACECARNINE; METHOTREXATE; METHYLENE BLUE; MITOTANE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXALIPLATIN; PACLITAXEL; THALIDOMIDE; VINCRISTINE;

APLASTIC ANEMIA; CANCER PAIN; CANCER REHABILITATION; CANCER SURGERY; CARDIOVASCULAR DISEASE; CONSTIPATION; DELIRIUM; DISEASE SEVERITY; DROWSINESS; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPONATREMIA; KIDNEY FAILURE; LIVER DISEASE; NAUSEA; NEUROPATHIC PAIN; NEUROPATHY; ORTHOSTATIC HYPOTENSION; PAIN; PAIN ASSESSMENT; PEPTIC ULCER; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SOMNOLENCE; STEVENS JOHNSON SYNDROME; URINE RETENTION; VISCERAL PAIN; XEROSTOMIA;

EID: 34247882861     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20780     Document Type: Review

References (76)

1. Silver JK: Chronic pain and the family. Cambridge: Harvard University Press; 2004; p. 10.
2. Apfelbaum JL, Chen C, Mehta SS, et al.: Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-540.
3. Cherny NI, Portenoy RK: The management of cancer pain. CA Cancer J Clin 2000;44:262-303.
4. Johanson GA: Symptom character and prevalence during cancer patients' last days of life. Am J Hosp Palliat Care 1991; 8:6-8, 18.
5. Bonica JJ, Ventafridda V, Twycross RG: Cancer pain. In: Bonica JJ, editor. The Management of Pain, ed. 2. Philadelphia: Lea & Febiger; 1990; pp 400-460.
6. Coyle N, Adelhardt J, Foley KM, et al.: Character of terminal illness in the advanced cancer patient: Pain and other symptoms during last four weeks of life. J Pain Symptom Manag 1990;5:83-93.
7. Portenoy RK, Miransky J, Thaler HT, et al.: Pain in ambulatory patients with lung or colon cancer: Prevalence, characteristics, and effect. Cancer 1992;70:1616-1624.
8. Twycross RG, Fairfield S: Pain in far-advanced cancer. Pain 1982;14:303-310.
9. Brescia FJ, Adler D, Gray G, et al.: Hospitalized advanced cancer patients: A profile. J Pain Symptom Manage 1990;5:221-227.
10. Ventafridda V, Ripamonti C, De Conno F, et al.: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
11. Massie MJ, Holland JC: The cancer patient with pain: Psychiatric complications and their management. Med Clin North Am 1987;71:243-258.
12. Cheville AL: Pain management in cancer rehabilitation. Arch Phys Med Rehabil 2001;82:S84-S87.
13. Van Wilgen CP, Dijkstra PU, van der Laan BFAM, et al.: Shoulder complaints after nerve sparing neck dissections. Int J Oral Maxillofac Surg 2004;33:253-257.
14. Chang HM: Cancer pain management. Med Clin North Am 1999;83:711-736.
15. Tishelman C, Degner LF, Rudman A, et al.: Symptoms in patients with lung carcinoma. Cancer 2005;104:2013-2021.
16. Rustoen T, Fossa SD, Skarstein J, et al.: The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage 2003;26:696-704.
17. Talbot M, Turcotte RE, Isler M, et al.: Function and health status in surgically treated bone metastases. Clin Orthop Relat Res 2005;438:215-220.
18. Wang XS, Cleeland CS, Mendoza TR, et al.: The effects of pain severity on health-related quality of life. Cancer 1999;86:1848-1855.
19. Meuser T, Pietruck C, Radbruch L, et al.: Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001;93:247-257.
20. Lucas LK, Lipman AG: Recent advances in pharmacotherapy for cancer pain management. Cancer Pract 2002;10:S14-S20.
21. Przewlocki R, Przewlocka B: Opioids in chronic pain. Eur J Pharmacol 2001;429:79-91.
22. Reid CM, Martin RM, Sterne JA, et al.: Oxycodone for cancer related pain: Meta-analysis of randomized control trials. Arch Intern Med 2006;166:837-843.
23. Marinangeli F, Ciccozzi A, Leonardis M, et al.: Use of strong opioids in advanced cancer pain: A randomized trial. J Pain Symptom Manage 2004;27:409-416.
24. Zech DF, Grond S, Lynch J, et al.: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain 1995;63:65-76.
25. Walsh D: Advances in opioid therapy and formulations. Support Care Cancer 2005;13:138-144.
26. Hanks GW, Nugent M, Higgs CM, et al.: OTFC Multicentre Study Group. Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: An open, multi-centre, dose-titration and long-term use study. Palliat Med 2004;18:698-704.
27. Smith TJ, Staats PS, Deer T, et al.: Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-4049.
28. Watkins T, Maxeiner A: Musculoskeletal effects of ovarian cancer and treatment: A physical therapy perspective. Rehabil Oncol 2003;21:12-17.
29. McTiernan A: Physical activity after cancer: Physiologic out-comes. Cancer Invest 2004;22:68-81.
30. Lee I-M: Physical activity and cancer prevention-Data from epidemiologic studies. Med Sci Sports Exerc 2003;35:1823-1827.
31. Courneya KS: Exercise in cancer survivors: An overview of research. Med Sci Sports Exerc 2003;35:1846-1852.
32. Westerlind KC: Physical activity and cancer prevention-Mechanisms. Med Sci Sports Exerc 2003;35:1834-1840.
33. Chlebowski RT, Aiello E, McTiernan A: The potential for weight loss in breast cancer management. J Clin Oncol 2002;20:1128-1143.
34. Fairey AS, Courneya KS, Field CJ, et al.: Physical exercise and immune system function in cancer survivors. Cancer 2002;94: 539-551.
35. Eisenberg DM, Kessler RC, Foster C, et al.: Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.
36. Weiger WA, Smith M, Boon H, et al.: Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889-903.
37. Benedetti C, Brock C, Cleeland C, et al.: NCCN practice guidelines for cancer pain. Oncology 2000;14:135-150.
38. Burton AW, Reddy SK, Shah HN, et al.: Percutaneous vertebroplasty-A technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case series. J Pain Symptom Manage 2005;30:87-95.
39. Meyerson BA: Neurosurgical approaches to pain treatment. Acta Anesthesiol Scand 2001;45:1108-1113.
40. Cheville AL: Pain management in cancer rehabilitation. Arch Phys Med Rehabil 2001;82:S84-S87.
41. Turk DC, Monarch ES, Williams AD: Cancer patients in pain: Considerations for assessing the whole person. Hematol Oncol Clin North Am 2002;16:511-525.
42. Juarez G, Cullinane CA, Borneman T, et al.: Management of pain and nausea in outpatient surgery. Pain Manag Nurs 2005;6:175-181.
43. Kim MC, Kim KH, Kim HH, et al: Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer. J Surg Oncol 2005;91:90-94.
44. Marchettini P, Formaglio F, Lacerenza M: Iatrogenic painful neuropathic complications of surgery in cancer. Acta Anaesthesiol Scand 2001;45:1090-1094.
45. Cavaliere R, Schiff D: Neurologic toxicities of cancer therapies. Curr Neurol Neurosci Rep 2006;6:218-226.
46. Zech DF, Grond S, Lynch J, et al.: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain 1995;63:65-76.
47. Centeno C, Sanz A, Bruera E: Delirium in advanced cancer patients. Palliat Med 2004;18:184-194.
48. Lawlor PG: The panorama of opioid-related cognitive dysfunction in patients with cancer: Pa critical literature appraisal. Cancer 2002;94:1836-1853.
49. Leppert W, Luczak J: The role of tramadol in cancer pain treatment-A review. Support Care Cancer 2005;13:5-17. Epub 2004 Nov 18.
50. Morita T, Takigawa C, Onishi H, et al.: Japan Pain, Rehabilitation, PalliativeMedicine, and Psycho-Oncology (PRPP) Study Group. Opioid rotation from morphine to fentanyl in delirious cancer patients: An open-label trial. J Pain Symptom Manage 2005;30: 96-103.
51. Hanna A, Sledge G, Mayer ML, et al.: A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 2006;14:210-215. Epub 2005.
52. Slatkin NE, Rhiner M: Treatment of opiate-related sedation: Utility of the cholinesterase inhibitors. J Support Oncol 2003;53-63.
53. Mazzocato C, Stiefel F, Buclin T, et al.: Psychopharmacology in supportive care of cancer: A review for the clinician: II. Neuroleptics. Support Care Cancer 2000; 89-97.
54. De Schepper HU, Cremonini F, Park MI, et al.: Opioids and the gut: Pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16:383-394.
55. Agra Y, Sacristan A, Gonzalez M, et al.: Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage 1998;15:1-7.
56. Wirz S, Klaschik E: Management of constipation in palliative care patients undergoing opioid therapy: Is polyethylene glycol an option? Am J Hosp Palliat Care 2005;22:375-381.
57. Kurz A, Sessler DI: Opioid-induced bowel dysfunction: Pathophysiology and potential new therapies. Drugs 2003;63:649-671.
58. Van Seventer R, Smit JM, Schipper RM, et al.: Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003;19:457-469.
59. FDA Consum. Warning on fentanyl patch FDA Consum 2005;39:4.
60. Wiffen P, Collins S, McQuay H, et al.: Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005;CD001133.
61. Abernethy AP, Samsa GP, Matchar DB: A clinical decision and economic analysis model of cancer pain management. Am J Manag Care 2003;9:651-664.
62. Green Cr,Ndao-Brumbley SK, West B, et al.: Differences in prescription opioid analgesic availability: Comparing minority and white pharmacies across Michigan. J Pain 2005;6:689-699.
63. Peretti-Watel P, Bendiane MK, Obadia Y, et al.: The South-Eastern France Palliative Care Group. The prescription of opioid analgesics to terminal cancer patients: Impact of physicians' general attitudes and contextual factors. Palliat Support Care 2003;1:345-352.
64. Furstenberg CT, Ahles TA, Whedon MB, et al.: Knowledge and attitudes of health-care providers toward cancer pain management: A comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage 1998;15:335-349.
65. Von Roenn JH, Cleeland CS, Gonin R, et al.: Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993;119: 121-126.
66. DaM JL: How to reduce fears of legal/regulatory scrutiny in managing pain in cancer patients. J Support Oncol 2005;3:384-388.
67. Cella DF, Tulsky DS, Gray G, et al.: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993;11:570-579.
68. Coscarelli Schag CA, Heinrich RL: Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990;4:135-138.
69. Coscarelli Schag CA, Ganz PA, Heinrich RL: Cancer rehabilitation evaluation system-Short form (CARES-SF). Cancer 1991;68:1406-1413.
70. Spitzer WO, Dobson AJ, Hall J, et al.: Measuring the quality of life of cancer patients: A concise QL index for use by physicians. J Chron Dis 1981;34:585-597.
71. Watt-Watson JH, Graydon JE: Sickness impact profile: A measure of dysfunction with chronic pain patients. J Pain Sympt Mgmt 1989;4:152-156.
72. Bardsley MJ, Astell S, McCallum A, et al.: The performance of three measures of health status in an outpatient diabetes population. Diabet Med 1993;10:619-626.
73. Hays RD, Sherbourne CD, Mazel RM, The RAND: 36-item health survey 1.0. Health Econ 1993;2:217-227.
74. Aaronson NK, Bullinger M, Ahmedzai S: A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 1988;111:231-249.
75. Aaronson NK, Ahmedzai S, Bergman B, et al.: The European organisation for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
76. Watson M, Law M, Maguire GP, et al.: Further development of a quality of life measure for cancer patients: The Rotterdam symptom checklist (revised). Psycho-Oncol 1992;1: 35-44.